DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY

Clinical trials for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY explained in plain language.

Never miss a new study

Get alerted when new DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY trials appear

Sign up with your email to follow new studies for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1

New hope for severe childhood epilepsy: experimental drug enters final testing phase

Disease control Recruiting now

This study is testing whether an investigational drug called LP352 can safely reduce seizure frequency in children and adults with severe developmental and epileptic encephalopathies (DEE). Researchers will compare LP352 against a placebo in about 320 participants over approximat…

Matched conditions: DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY

Phase: PHASE3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY

Get alerted when new DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY trials appear

New hope for severe childhood epilepsy: experimental drug enters final testing phase